熱門資訊> 正文
CASI Pharmaceuticals宣布任命首席执行官
2025-07-22 04:21
- 英創遠達製藥(CASI) 0
- 塞拉尼斯(CE) 0
- 纳比特(NA) 0
- CASI Pharmaceuticals (NASDAQ:CASI) has named David Cory as its new chief executive officer and board member.
- Wei-Wu He, Ph.D., will step down as CEO and transition to the role of executive chairman of the board.
- Cory previously served as CEO of LIB Therapeutics, leading Phase 3 trials and a regulatory filing for a cardiovascular therapy.
- CASI shares up 3.3% post-market on Monday.
- Source: Press release
More on CASI Pharmaceuticals
- Seeking Alpha’s Quant Rating on CASI Pharmaceuticals
- Historical earnings data for CASI Pharmaceuticals
- Financial information for CASI Pharmaceuticals
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
